Novel Approaches to Causality Adjudication in Drug-Induced Liver Disease

Curr Hepatol Rep. 2018 Sep;17(3):276-282. doi: 10.1007/s11901-018-0416-8. Epub 2018 Jul 11.

Abstract

Purpose of review: Drug induced liver injury (DILI) is a complex diagnosis dominantly based of exclusion.

Recent findings: Currently available causality assessment instruments are considered to be suboptimal. Expert opinion appears to be best method to adjudicate causality, but is impractical to implement on a wide scale basis. Thus, new approaches are needed, for example improving the specificity of current scoring systems. A further option would be to develop a system that utilizes computer-based scoring - which would reduce human error. Additionally, it would be ideal to have available drug specific scoring systems, based on drugs' characteristic "phenotypes" (presentation and pattern of injury). Eventually, a validated system could be integrated within the electronic health information system.

Summary: This review highlights an avenue to an improved Causality Assessment Tool.

Keywords: Causality; Drug induced liver injury; liver disease; scoring system.